Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
Reaction mass of 6-(2-ethyl-6-methylanilino)-5-(4-{4-[ethyl(3-sulfobenzyl) amino] phenylazo} phenylazo)-4-hydroxynaphthalene-2-sulfonic acid, sodium and/or disodium salt(s) and 6-(2-ethyl-6-methylanilino)-5-(4-{4-[ethyl(4-sulfobenzyl) amino] phenylazo} phenylazo)-4-hydroxynaphthalene-2-sulfonic acid, sodium and/or disodium salt(s)
EC number: 475-080-7 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Genetic toxicity: in vitro
Administrative data
- Endpoint:
- in vitro cytogenicity / chromosome aberration study in mammalian cells
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 007
- Report date:
- 2007
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 473 (In Vitro Mammalian Chromosomal Aberration Test)
- Version / remarks:
- 1997
- GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- in vitro mammalian chromosome aberration test
Test material
- Reference substance name:
- Acid Navy RN-2682
- IUPAC Name:
- Acid Navy RN-2682
- Test material form:
- solid
Constituent 1
Method
Species / strain
- Species / strain / cell type:
- Chinese hamster lung fibroblasts (V79)
- Metabolic activation:
- with and without
- Metabolic activation system:
- S9-mix
- Test concentrations with justification for top dose:
- Concentration range in the main test (with metabolic activation): 93.8 ... 3000 µg/ml
Concentration range in the main test (with metabolic activation): 46.9 ... 1500 µg/ml
Concentration range in the main test (without metabolic activation): 93.8 ... 3000 µg/ml
Concentration range in the main test (without metabolic activation): 11.7 ... 1500 µg/ml - Vehicle / solvent:
- Deionised water.
Controls
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- no
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- cyclophosphamide
- ethylmethanesulphonate
- Details on test system and experimental conditions:
- A pre-test on cell growth inhibition with 4 hrs and 24 hrs treatment was performed in order to determine the toxicity of the test item. Cytotoxicity was determined using concentrations separated by no more than a factor of 2 - sqrt10. The general experimental conditions in this pre-test were the same as described below for the cytogenetic main experiment. The following method was used:
in a quantitative assessment, exponentially growing cell cultures (seeding about 40,000 cells/ slide, with regard to the culture time 48 hrs) were treated with the test item for simulating the conditions of the main experiment. A qualitative evaluation of cell number and cell morphology was made 4 hrs and 24 hrs after start of treatment. The cells were stained 24 hrs after start of treatment. Using a 400-fold microscopic magnification the cells were counted in 10 coordinate defined fields of the slides (2 slides per treatment group). The cell number of the treatment groups is given as % cells in relation to the control.
Dose selection
The highest concentration used in the cytogenetic experiments was chosen with regard to the current OECD Guideline for in vitro mammalian cytogenetic tests requesting for the top concentration clear toxicity with reduced cell numbers or mitotic indices below 50 % of control, whichever is the lowest concentration, and/or the occurrence of precipitation. In case of non-toxicity the maximum concentration should be 5 mg/ml, 5 µL/ml or 10 mM,
whichever is the lowest, if formulation in an appropriate solvent is possible.
In the pre-test, 7150 µg/ml (similar active ingredient, purity: approx. 70 %) was applied as top concentration for treatment of the cultures. Test item concentrations between 55.9 and 7150 µg/ml (with and without S9 mix) were chosen for the evaluation of cytotoxicity.
Using reduced cell numbers as an indicator for toxicity in the pre-test, clear toxic effects were observed after 4 hrs treatment with 1787.5 µg/ml and above in the absence of S9 mix.
In addition, 4 hrs treatment with 893.8 µg/ml and above in the presence of S9 mix induced strong toxic effects. Considering the toxicity data of the pre-test, 3000 µg/ml (with and without S9 mix) was chosen as top concentration in Experiment I.
Dose selection of Experiment II was also influenced by test item toxicity. In the range finding experiment, clearly reduced cell numbers were observed after 24 hrs exposure with 446.9 µg/ml and above. Therefore, 1500 µg/ml was chosen as top treatment concentration for continuous exposure in the absence of S9 mix. In the presence of S9 mix, 1500 µg/ml was chosen as top treatment concentration with respect to the results obtained in Experiment I. Due to a technical error, the experimental part with S9 mix was repeated with the same top test item concentration.
Doses applied without S9 mix:
preparation interval exposure period exp. conc. in µg/ml
18 h 4 h I 93.8 - 3000
18 h 18 h II 11.7 - 1500
28 h 28 h II 11.7 - 1500
Doses appplied with S9 mix:
preparation interval exposure period exp. conc. in µg/ml
18 h 4 h I 93.8 - 3000
28 h 4 h II (repeated) 46.9 - 1500
28 h 4 h II 46.9 - 1500 (precipitation seen 4 h after start of treatment at 375, 750, 1500)
Results and discussion
Test results
- Species / strain:
- Chinese hamster lung fibroblasts (V79)
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- True negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Additional information on results:
- Using reduced cell numbers as an indicator for toxicity in
the pre-test, clear toxic effects were observed after 4 hrs
treatment with 1787.5 µg/ml and above in the absence of S9 mix. In addition, 4 hrs treatment with 893.8 µg/ml and above
in the presence of S9 mix induced strong toxic effects.
Considering the toxicity data of the pre-test, 3000 µg/ml (with and without S9 mix) was chosen as top concentration in Experiment I.
Dose selection of Experiment II was also influenced by test item toxicity. In the range finding experiment, clearly reduced cell numbers were observed after 24 hrs exposure with 446.9 µg/ml and above. Therefore, 1500 µg/ml was chosen as top treatment concentration for continuous exposure in the absence of S9 mix. In the presence of S9 mix, 1500 µg/ml was chosen as top treatment concentration with respect to the results obtained in Experiment I. Due to a technical error, the experimental part with S9 mix was repeated with the same top test item concentration.
In both independent experiments, no biologically relevant increase in the number of cells carrying structural chromosomal aberrations was observed after treatment with the test item. However, in Experiment II, in the presence of S9 mix, two statistically significant increases in the number of aberrant cells, excluding gaps were observed after treatment with 93.8 and 187.5 µg/ml (1.5 % and 4.0 %, respectively). Since both values were clearly within the range of laboratory historical control data (0.0 - 4.0 % aberrant cells, excluding gaps), this observation has to be regarded as biologically irrelevant. No relevant increase in the frequencies of polyploid metaphases was found after treatment with the test item as compared to the frequencies of the controls.
Appropriate mutagens were used as positive controls. They induced statistically significant increases (p < 0.05) in cells with structural chromosome aberrations.
Applicant's summary and conclusion
- Conclusions:
- Negative with and without metabolic activation.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.

EU Privacy Disclaimer
This website uses cookies to ensure you get the best experience on our websites.